about
Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancerAn integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiationDefects in mucosal immunity leading to Crohn's diseasePatients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cellsInteraction between Mesenchymal Stem Cells and B-CellsAnimal models to study acute and chronic intestinal inflammation in mammalsInflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsImmunomodulatory functions of type I interferonsA New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR EffectOsteopontin and mucosal protectionUbiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expressionCytokines as biomarkers of nanoparticle immunotoxicityCD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitisLoss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasiaIntranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in miceEpicatechin used in the treatment of intestinal inflammatory disease: an analysis by experimental models.The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitisGut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice.Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.GanedenBC30 cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro.MicroRNA155 is induced in activated CD4(+) T cells of TNBS-induced colitis in mice.Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens.The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.Air Pollution and Climate Change Effects on Allergies in the Anthropocene: Abundance, Interaction, and Modification of Allergens and Adjuvants.Contribution of genetics to a new vision in the understanding of inflammatory bowel disease.Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell functionStem cells as potential therapeutic targets for inflammatory bowel disease.Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3Signaling pathways that lead to the silencing of the interleukin-4-producing potential in Th1 cells.Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine.Optimizing the GATA-3 position weight matrix to improve the identification of novel binding sites.Isoflavones, genistein and daidzein, regulate mucosal immune response by suppressing dendritic cell functionInflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.Plasma interleukin-18 reflects severity of ulcerative colitis.Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.Selective exposure of the fetal lung and skin/amnion (but not gastro-intestinal tract) to LPS elicits acute systemic inflammation in fetal sheep.NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model.Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
P2860
Q21089654-B307128B-DB1B-4568-99E1-4E07D192AAD2Q21093377-1CE73955-FCBB-46C8-87DB-ADD1D7B2F323Q22242645-E5DEE591-BB0E-4EBA-9339-81BEBDF75C39Q24685469-2E328D2E-5E3B-4112-8BE6-80A2B753152BQ26750859-793D193F-9E16-40BA-B9B1-D7B5A988DE89Q26777430-0841B4F0-37D6-45A1-862B-7C104C0CFF90Q26785537-983C6641-C6F1-4617-9839-7AFB4207CD07Q26823904-D3B491B9-E038-41AD-8AE7-F5CAFA2D357DQ27300754-12BDEA71-E822-4F6F-8D0C-61DE3575BE07Q28236080-36053E97-4C24-4FA8-AC37-FF03799DB1A0Q28245792-6893F4A6-C9EE-4819-826D-2C5B4F828874Q28383550-EF74490D-670A-4255-9B20-4478CABB56D9Q28570900-E276FD33-4F4F-4F54-A453-1ADC0EBFEADEQ28591205-B3B2E17A-BA49-4C9B-A8B2-6D9A6CA8D744Q28744391-99CAFE89-92FD-4586-8D66-A499B7C71E9BQ30394372-6C336AD9-BA25-4BC7-B376-E34BAB97B506Q30483252-9427587A-D157-4BD7-A2D0-3F466205B027Q30850600-B5C5EC23-549D-4CA0-9D0C-2CCBB72087F9Q33264524-0668B285-C38E-48D8-B581-F59912707B86Q33544931-D7A1F14C-BEDF-4C76-82CD-A913E32A304AQ33672851-B6374A33-147F-49C0-BD71-7411CCA00D9BQ33729299-10385597-62EB-49B8-BCE2-12A67EAFB474Q33731751-56E8F98C-6F59-4C36-81BF-667BFA188AC4Q33752095-E89032C9-7134-4309-B692-5C32B8A44A8FQ33866970-EB3D82C2-859E-4204-AC45-ED9EA31061FCQ33896386-56B5A659-540F-4D3F-9D2F-8BF98E80821AQ33975300-6CEE65BB-F659-45BC-8B04-567CDBBBA0EAQ33994753-773EA913-5934-4EFF-BA2F-BCC534F2FFB0Q34208020-3F19A44E-CFEE-41F3-AE30-83C49AC23D7EQ34283105-5A060790-1A93-442C-9D23-1990FF89F151Q34389964-15EB09B5-4CCE-4E68-B98E-91EBFF8D8293Q34460804-85BA4C3D-DF96-4311-BEEF-D43506C7EB24Q34519827-1070607B-F785-4768-85DE-218375BC7894Q34573050-F1119D36-B43C-4176-AC49-3DD4FD00B7EDQ34605860-FECADB17-DA33-46C3-AC5E-B043ACB3EADCQ34607579-46ABBB6F-C72F-473F-9BA4-953C22F90C56Q34611580-E008C8FC-94A5-4238-AD39-DD33297C468EQ34730325-011E5D34-4647-4843-BFE9-C7F130516B75Q34763695-D3D4DE68-A800-4A11-876C-C223577BF270Q34785970-27A740F3-6213-4BD9-83DF-387622729A92
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of Th1/Th2 polarization in mucosal immunity.
@ast
The role of Th1/Th2 polarization in mucosal immunity.
@en
The role of Th1/Th2 polarization in mucosal immunity.
@nl
type
label
The role of Th1/Th2 polarization in mucosal immunity.
@ast
The role of Th1/Th2 polarization in mucosal immunity.
@en
The role of Th1/Th2 polarization in mucosal immunity.
@nl
prefLabel
The role of Th1/Th2 polarization in mucosal immunity.
@ast
The role of Th1/Th2 polarization in mucosal immunity.
@en
The role of Th1/Th2 polarization in mucosal immunity.
@nl
P2093
P356
P1433
P1476
The role of Th1/Th2 polarization in mucosal immunity.
@en
P2093
Laurie H Glimcher
Markus F Neurath
Susetta Finotto
P2888
P304
P356
10.1038/NM0602-567
P407
P577
2002-06-01T00:00:00Z